FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2796359275> ?p ?o ?g. }

• W2796359275 abstract "The antitumoral effects of different Toll-like receptor (TLRs) agonists is mediated by activating immune responses to suppress tumors growth, although TLR ligands may also have a direct effect on tumoral cells. Given that TLR signaling induces hematopoietic cell differentiations this may serve as a novel differentiation therapeutic approach for AML.We investigated the effects of agonists for the ten human TLRs on the proliferation, apoptosis, cell cycle and differentiation of ten different types of myeloid leukemia cell lines (HL-60, U-937, KG-1, KG-1a, K-562, Kasumi-1, EOL-1, NB4, MOLM-13 and HEL). Proliferation was measured using the CellTiter 96® Aqueous One Solution Cell Proliferation Assay (Promega). Staining and analysis with a flow cytometer was used to identify cell cycle progression and apoptosis. Differentiation was measured by staining cells with the EuroFlow™ antibody panel for AML and analyzed by flow cytometry. FlowJo software was used to analyze the cytometric data. In all experiments, statistical significance was determined by a two-tailed t test.The activation of particular TLRs on some cell lines can induce growth inhibition and Imiquimod (a TLR 7 agonist) was the most effective agonist in all leukemic cell lines examined. Imiquimod was able to induce apoptosis, as well as to induce cell cycle alteration and upregulation of myeloid differentiation markers on some of the cell lines tested.Our results, together with the known efficacy of Imiquimod against many tumor entities, suggest that Imiquimod can be a potential alternative therapy to AML. This drug has a direct cytotoxic effect on leukemic cells, has the potential to induce differentiation, and can also stimulate the activation of cellular immune responses anti-AML." @default.
• W2796359275 created "2018-04-13" @default.
• W2796359275 creator A5030067333 @default.
• W2796359275 creator A5035199250 @default.
• W2796359275 creator A5049626267 @default.
• W2796359275 creator A5067351544 @default.
• W2796359275 creator A5068275399 @default.
• W2796359275 creator A5071209698 @default.
• W2796359275 date "2018-01-30" @default.
• W2796359275 modified "2023-10-16" @default.
• W2796359275 title "Imiquimod inhibits growth and induces differentiation of myeloid leukemia cell lines" @default.
• W2796359275 cites W1604691790 @default.
• W2796359275 cites W1846953774 @default.
• W2796359275 cites W1977758974 @default.
• W2796359275 cites W1978869743 @default.
• W2796359275 cites W1991254329 @default.
• W2796359275 cites W2000750280 @default.
• W2796359275 cites W2004621173 @default.
• W2796359275 cites W2008039255 @default.
• W2796359275 cites W2054856002 @default.
• W2796359275 cites W2064422200 @default.
• W2796359275 cites W2073785960 @default.
• W2796359275 cites W2082717876 @default.
• W2796359275 cites W2087143957 @default.
• W2796359275 cites W2090630520 @default.
• W2796359275 cites W2114441791 @default.
• W2796359275 cites W2129036118 @default.
• W2796359275 cites W2129053095 @default.
• W2796359275 cites W2169988783 @default.
• W2796359275 cites W2174883931 @default.
• W2796359275 cites W2209389920 @default.
• W2796359275 cites W2324890158 @default.
• W2796359275 cites W2414333256 @default.
• W2796359275 cites W2559537906 @default.
• W2796359275 cites W2571229748 @default.
• W2796359275 cites W2582670998 @default.
• W2796359275 doi "https://doi.org/10.1186/s12935-018-0515-1" @default.
• W2796359275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5791367" @default.
• W2796359275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29422777" @default.
• W2796359275 hasPublicationYear "2018" @default.
• W2796359275 type Work @default.
• W2796359275 sameAs 2796359275 @default.
• W2796359275 citedByCount "14" @default.
• W2796359275 countsByYear W27963592752019 @default.
• W2796359275 countsByYear W27963592752020 @default.
• W2796359275 countsByYear W27963592752021 @default.
• W2796359275 countsByYear W27963592752022 @default.
• W2796359275 countsByYear W27963592752023 @default.
• W2796359275 crossrefType "journal-article" @default.
• W2796359275 hasAuthorship W2796359275A5030067333 @default.
• W2796359275 hasAuthorship W2796359275A5035199250 @default.
• W2796359275 hasAuthorship W2796359275A5049626267 @default.
• W2796359275 hasAuthorship W2796359275A5067351544 @default.
• W2796359275 hasAuthorship W2796359275A5068275399 @default.
• W2796359275 hasAuthorship W2796359275A5071209698 @default.
• W2796359275 hasBestOaLocation W27963592751 @default.
• W2796359275 hasConcept C190283241 @default.
• W2796359275 hasConcept C203014093 @default.
• W2796359275 hasConcept C2778461978 @default.
• W2796359275 hasConcept C2778729363 @default.
• W2796359275 hasConcept C2779112978 @default.
• W2796359275 hasConcept C2779282312 @default.
• W2796359275 hasConcept C29537977 @default.
• W2796359275 hasConcept C502942594 @default.
• W2796359275 hasConcept C54355233 @default.
• W2796359275 hasConcept C553184892 @default.
• W2796359275 hasConcept C55493867 @default.
• W2796359275 hasConcept C62112901 @default.
• W2796359275 hasConcept C81885089 @default.
• W2796359275 hasConcept C86803240 @default.
• W2796359275 hasConcept C95444343 @default.
• W2796359275 hasConceptScore W2796359275C190283241 @default.
• W2796359275 hasConceptScore W2796359275C203014093 @default.
• W2796359275 hasConceptScore W2796359275C2778461978 @default.
• W2796359275 hasConceptScore W2796359275C2778729363 @default.
• W2796359275 hasConceptScore W2796359275C2779112978 @default.
• W2796359275 hasConceptScore W2796359275C2779282312 @default.
• W2796359275 hasConceptScore W2796359275C29537977 @default.
• W2796359275 hasConceptScore W2796359275C502942594 @default.
• W2796359275 hasConceptScore W2796359275C54355233 @default.
• W2796359275 hasConceptScore W2796359275C553184892 @default.
• W2796359275 hasConceptScore W2796359275C55493867 @default.
• W2796359275 hasConceptScore W2796359275C62112901 @default.
• W2796359275 hasConceptScore W2796359275C81885089 @default.
• W2796359275 hasConceptScore W2796359275C86803240 @default.
• W2796359275 hasConceptScore W2796359275C95444343 @default.
• W2796359275 hasIssue "1" @default.
• W2796359275 hasLocation W27963592751 @default.
• W2796359275 hasLocation W27963592752 @default.
• W2796359275 hasLocation W27963592753 @default.
• W2796359275 hasLocation W27963592754 @default.
• W2796359275 hasLocation W27963592755 @default.
• W2796359275 hasOpenAccess W2796359275 @default.
• W2796359275 hasPrimaryLocation W27963592751 @default.
• W2796359275 hasRelatedWork W2347239577 @default.
• W2796359275 hasRelatedWork W2350294409 @default.
• W2796359275 hasRelatedWork W2354128257 @default.
• W2796359275 hasRelatedWork W2363671651 @default.
• W2796359275 hasRelatedWork W2379033026 @default.
• W2796359275 hasRelatedWork W2384823831 @default.

• next